{"bill":{"bill_id":1716288,"change_hash":"cb72addb72d288813ac0d35c39260048","session_id":2003,"session":{"session_id":2003,"state_id":43,"year_start":2023,"year_end":2024,"prefile":0,"sine_die":0,"prior":0,"special":0,"session_tag":"Regular Session","session_title":"2023 Regular Session","session_name":"88th Legislature Regular Session"},"url":"https:\/\/legiscan.com\/TX\/bill\/HB2529\/2023","state_link":"https:\/\/capitol.texas.gov\/BillLookup\/History.aspx?LegSess=88R&Bill=HB2529","completed":0,"status":1,"status_date":"2023-02-21","progress":[{"date":"2023-02-21","event":1}],"state":"TX","state_id":43,"bill_number":"HB2529","bill_type":"B","bill_type_id":"1","body":"H","body_id":91,"current_body":"H","current_body_id":91,"title":"Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability.","description":"Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability.","pending_committee_id":0,"committee":[],"referrals":[],"history":[{"date":"2023-02-21","action":"Filed","chamber":"H","chamber_id":91,"importance":1}],"sponsors":[{"people_id":20246,"person_hash":"7sckis05","party_id":"1","state_id":43,"party":"D","role_id":1,"role":"Rep","name":"James Talarico","first_name":"James","middle_name":"","last_name":"Talarico","suffix":"","nickname":"","district":"HD-052","ftm_eid":44105627,"votesmart_id":177454,"opensecrets_id":"","knowwho_pid":647757,"ballotpedia":"James_Talarico","bioguide_id":"","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[{"type_id":1,"type":"Same As","sast_bill_number":"SB241","sast_bill_id":1633573}],"subjects":[{"subject_id":5273,"subject_name":"Health"},{"subject_id":5554,"subject_name":"Health--Other Diseases & Medical Conditions"},{"subject_id":5393,"subject_name":"Insurance"},{"subject_id":5497,"subject_name":"Insurance--Health & Accident"},{"subject_id":6091,"subject_name":"DIABETES"},{"subject_id":5336,"subject_name":"MEDICINE & PRESCRIPTION DRUGS"},{"subject_id":5444,"subject_name":"HEALTH & HUMAN SERVICES COMMISSION"}],"texts":[{"doc_id":2710656,"date":"2023-02-21","type":"Introduced","type_id":1,"mime":"text\/html","mime_id":1,"url":"https:\/\/legiscan.com\/TX\/text\/HB2529\/id\/2710656","state_link":"https:\/\/capitol.texas.gov\/tlodocs\/88R\/billtext\/html\/HB02529I.htm","text_size":9777,"text_hash":"5f5fcb3d36b348e3b955d5733ebcc2ec"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}